Key figures of the business segments

	FRESENIUS MEDICAL CARE			FRESENIUS KABI

	Dialysis products, Dialysis care, Extracorporeal therapies			Infusion therapy, Clinical nutrition, Transfusion technology
	2007 in mill. US$	2006 in mill. US$	Change	2007 in million €	2006 in million €	Change
Sales	9,720	8,499	14%	2,030	1,893	7%
EBIT	1,580	1,318	20%	332	291	14%
Net income	717	537	34%	183	143	28%
Operating cash flow	1,200	908	32%	179	202	-11%
Capital expenditure/acquisitions	932	4,783	-81%	294	127	--
R & D expenses	67	51	31%	86	77	12%
Employees (December 31)	64,662	59,996	8%	16,964	15,591	9%

	FRESENIUS HELIOS			FRESENIUS VAMED

	Hospital operation			Engineering and Services for hospitals and other health care facilities
	2007 in million €	2006 in million €	Change	2007 in million €	2006 in million €	Change
Sales	1,841	1,673	10%	408	392	4%
EBIT	155	133	17%	26	23	13%
Net income	64	59	8%	23	20	15%
Operating cash flow	202	141	43%	72	34	112%
Capital expenditure/acquisitions	323	214	51%	10	5	100%
Order Intake	n/a	n/a		395	337	17%
Employees (December 31)	30,043	26,368	14%	1,767	1,768	0%

As from January 1, 2008, Fresenius ProServe was replaced by the two new business segments Fresenius Helios and Fresenius Vamed which previously formed Fresenius ProServe. Therefore, this new structure is already presented in this Annual Report. For Fresenius ProServe’s financial results please see the Management Report.

1 | 2